Skip to main content
Equibles
ATRA logo

ATRA · Atara Biotherapeutics, Inc. · Webcasts, Transcripts & Audio

Track ATRA — free

Use ATRA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ATRA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$9.40 -0.08 (-0.84%) At close · Oct 5
Rebalance outlook locked
Going-concern doubt — flagged Aug 12, 2026

Substantial doubt about the company's ability to continue as a going concern.

“Our existing cash, cash equivalents and short-term investments as of June 30, 2026 will not be sufficient to fund our planned operations for at least the next twelve months from the date of issuance of these financial statements. These conditions raise substantial doubt about our ability to continue as a going concern for at least 12 months after the issuance of the accompanying condensed consolidated financial statements.”
View the 10-Q filed Aug 12, 2026
Market Cap
$82.31M
Shares
10.04M
Volume · Oct 5 39.34K Avg daily vol (3M) 57.9K

Atara Biotherapeutics, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Atara Biotherapeutics, Inc. (ATRA), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
· $7.31M −$88.11M '22 Q1 22-05-05 · $51.58M $18.47M '22 Q2 22-08-08 · $4.46M −$84.09M '22 Q3 22-11-08 LATEST ▼52.1% $2.14M −$69.80M '23 Q3 23-11-01
Earnings call
FY23 · Q3
2023-11-01
Atara Biotherapeutics, Inc. (ATRA) Q3 2023 Earnings Call Transcript
Revenue
$2.14M
▼ 52.1% YoY
Diluted EPS
$-16.40
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q3
2022-11-08
Atara Biotherapeutics, Inc. (ATRA) Q3 2022 Earnings Call Transcript
Revenue
$4.46M
Diluted EPS
$-20.50
Rev · 3q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-08
Atara Biotherapeutics, Inc. (ATRA) Q2 2022 Earnings Call Transcript
Revenue
$51.58M
Diluted EPS
$4.50
Rev · 2q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-05
Atara Biotherapeutics, Inc. (ATRA) Q1 2022 Earnings Call Transcript
Revenue
$7.31M
Diluted EPS
$-21.75
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-01-26
Atara Biotherapeutics, Inc. (ATRA) Q4 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-04
Atara Biotherapeutics, Inc. (ATRA) Q3 2021 Earnings Call Transcript
Diluted EPS
$-22.50
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-09
Atara Biotherapeutics, Inc. (ATRA) Q2 2021 Earnings Call Transcript
Diluted EPS
$-22.75
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-04
Atara Biotherapeutics, Inc. (ATRA) Q1 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-03-01
Atara Biotherapeutics, Inc. (ATRA) Q4 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-09
Atara Biotherapeutics, Inc. (ATRA) Q3 2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-05
Atara Biotherapeutics, Inc. (ATRA) Q2 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-06
Atara Biotherapeutics, Inc. (ATRA) Q1 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-02-27
Atara Biotherapeutics, Inc. (ATRA) Q4 2019 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Showing 1–13 of 13 webcasts
Key facts CIK 1604464 CUSIP 046513206 13F (30d) 1 filings 1 filers Visit website Investor relations